Global High Content Screening Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
The High Content Screening Market Report has been segmented on the basis of product, application, end-user, and region.
High Content Screening Market: Overview
The high Content Screening Market was valued at $24 million in 2020 & is projected to reach $34 million by 2030. It is expected to grow at a 5% CAGR between 2021 and 2030.
High content screening is also known as high-content analysis. It is an analytical method using automated microscopy, visualization tools for extracting quantitative data from cell populations, and multi-parameter for image processing.
High content screening involves fluorescence imaging of samples and reports quantitatively on multiple parameters.
High content screening technology integrates all aspects of drug discovery, including primary compound screening, post-primary screening, evaluation of ADME properties, and complex multivariate drug profiling.
High Content Screening Market: Dynamics
Increasing research and development activities for innovation and drug discovery for various diseases such as cancer, Alzheimer's, Parkinson’s, etc. is a key factor expected to drive the revenue growth of the target market over the next 10 years.
In addition, advancements in informatics solutions and imaging instruments, a growing geriatric population, and increasing health care expenditure, are some of the factors boosting the demand for high content screening globally.
Furthermore, rising awareness about health among individuals is playing a very important role in increasing demand for high content screening for various applications.
However, the high price of high content screening instruments, as well as the lack of knowledgeable and skilled professionals, are the factor expected to hamper the growth of the target market to a certain extent.
High Content Screening Market: Segment Analysis
On the basis of product segment, the instrument is expected to hold the largest market share. On the basis of the application segment, the toxicity studies segment is expected to witness the highest revenue share.
This is primarily to, increasing cases of adverse drug reactions in a large number of the patient pool. On the basis of the end-user segment, pharmaceutical and biotechnology companies are expected to register the fastest CAGR over the forecast period, due to increasing research activities for biological research and drug discovery.
High Content Screening Market: Trends
The major manufacturers are adopting various growth strategies such as merges, new launches, etc. as well as research activities are carried out for the application of HCS for personalized medicine, these are the key trend witnessed in the target market.
For instance, In October 2016, GE Healthcare launched IN Cell Image Analysis Software, which offers a fully integrated automation solution for its equipment in high content screening.
High Content Screening Market: Regional Analysis
In 2018, the markets in North America are anticipated to hold for highest revenue share in the target market. This is due to improved medical facilities, and growing awareness of government regarding healthcare wellness in countries in the region.
However, the market in the Asia Pacific is expected to witness the highest growth rate over the next 10 years, due to the growing emphasis on research and development activities in the health care sector, rising disposable income, and increasing need for novel drugs for the treatment of complex diseases in the Asia Pacific region.
High Content Screening Market Segmentation:
Segmentation by product:
- Cell Imaging and Analysis Systems
- Flow Cytometers
Segmentation by application:
- Primary and Secondary Screening
- Target Identification and Validation
- Toxicity Studies
- Compound Profiling
- Other Applications
Segmentation by end-user:
- Pharmaceutical and Biotechnology Companies
- Academic and Government Institutes
- Contract Research Organizations
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- GE Healthcare
- Danaher Corporation
- Perkinelmer, Inc.
- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company
- Biotek Instruments, Inc.
- Bio-Rad Laboratories, Inc.
- Tecan Group Ltd.
- Yokogawa Electric Corporation
- Genedata AG
Request for TOC
Don't just take our word. We are trusted by these great companies!